BioNano Genomics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:BioNano Genomics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7518
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioNano Genomics Inc (BioNano) is a developer of technology platform to analyze the segments of genomic DNA and other structural variations. The company’s products include irys chip, saphyr, genome mapping systems and prep kits. Its saphyr offers breakthrough speed and throughput with unmatched structural variation sensitivity ideal for human and translational research applications. BioNano’s prep kits are optimized to extract and label DNA for genome mapping systems. The company also offers data solutions which provide experiment management, analysis and bioinformatics processing. It conducts research across various areas including human disease, agricultural bioengineering, and genome discovery. BioNano also develops technologies such as platform technology, structural variation, genome assembly and DLS technology. The company sells its products through a network of distributors located in Taiwan, South Korea, Singapore, Malaysia, Indonesia, Japan, China, South Africa, the Czech Republic, Australia and New Zealand. BioNano is headquartered in San Diego, California, the US.

BioNano Genomics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioNano Genomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioNano Genomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioNano Genomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioNano Genomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
BioNano Genomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioNano Genomics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
BioNano Genomics Raises USD53 Million in Series C Venture Financing 10
BioNano Genomics Raises USD68.4 Million in Venture Financing 12
BioNano Genomics Raises USD5 Million in Venture Financing 13
BioNano Genomics Raises Funds through Venture Financing 14
BioNano Genomics Raises US$10 Million In Venture Financing 15
BioNano Genomics Raises US$10 Million In Series B-1 Financing 16
BioNano Genomics Raises US$8.8 Million In Venture Financing 17
Partnerships 18
Genoox Enters into Agreement with Bionano Genomics 18
Genoptix and Bionano Genomics Enter into Co-Development Agreement 19
Berry Genomics Enters into Agreement with BioNano Genomics 20
BioNano Genomics Enters into Research Agreement with University of California, Los Angeles 21
DNAnexus Enters into Agreement with BioNano Genomics 22
BGI to Enter into Co-Development Agreement with BioNano Genomics 23
Equity Offering 24
BioNano Genomics Prices IPO of Shares for USD20.6 Million 24
BioNano Genomics Inc – Key Competitors 26
BioNano Genomics Inc – Key Employees 27
BioNano Genomics Inc – Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Product News 29
Jan 12, 2018: Bionano Genomics’ Early-Access Customers to Present Groundbreaking Genome Assembly Data Using Bionano’s New Labeling Technology at PAG XXVI Conference 29
Apr 04, 2017: Bionano Genomics Announces Immediate Availability of New Suite of Genomic Analysis Tools 30
Feb 15, 2017: Results Presented at AGBT Demonstrate Clinical Significance of Next-Generation Mapping to Improve Serious Human Disease Research and Potentially Patient Outcomes 31
Feb 13, 2017: Bionano Genomics Announces Global Launch of Saphyr, its Newest and Most Advanced System for Genome Mapping and Structural Variation Analysis 33
Feb 07, 2017: Bionano Genomics Announces Multiple Presentations Demonstrating How Its Next-Generation Mapping Accelerates Pace of Human Disease Research at AGBT General Meeting 2017 35
Other Significant Developments 37
Sep 05, 2017: Bionano Genomics Announces Inversion Detection Algorithms With Unmatched Sensitivity 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
BioNano Genomics Inc, Medical Equipment, Key Facts 2
BioNano Genomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BioNano Genomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioNano Genomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioNano Genomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioNano Genomics Inc, Deals By Market, 2012 to YTD 2018 8
BioNano Genomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioNano Genomics Raises USD53 Million in Series C Venture Financing 10
BioNano Genomics Raises USD68.4 Million in Venture Financing 12
BioNano Genomics Raises USD5 Million in Venture Financing 13
BioNano Genomics Raises Funds through Venture Financing 14
BioNano Genomics Raises US$10 Million In Venture Financing 15
BioNano Genomics Raises US$10 Million In Series B-1 Financing 16
BioNano Genomics Raises US$8.8 Million In Venture Financing 17
Genoox Enters into Agreement with Bionano Genomics 18
Genoptix and Bionano Genomics Enter into Co-Development Agreement 19
Berry Genomics Enters into Agreement with BioNano Genomics 20
BioNano Genomics Enters into Research Agreement with University of California, Los Angeles 21
DNAnexus Enters into Agreement with BioNano Genomics 22
BGI to Enter into Co-Development Agreement with BioNano Genomics 23
BioNano Genomics Prices IPO of Shares for USD20.6 Million 24
BioNano Genomics Inc, Key Competitors 26
BioNano Genomics Inc, Key Employees 27

List of Figures
BioNano Genomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BioNano Genomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BioNano Genomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BioNano Genomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BioNano Genomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioNano Genomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
BioNano Genomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioNano Genomics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[BioNano Genomics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Core-Mark Holding Company, Inc.:企業の戦略・SWOT・財務分析
    Core-Mark Holding Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Core-Mark Holding Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Ignyta Inc (RXDX)-製薬・医療分野:企業M&A・提携分析
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc is a drug manufacturing company that discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. The company develops products using integrated therapeutic (Rx) and companion diagnost …
  • Transat A.T. Inc:企業の戦略・SWOT・財務分析
    Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report Summary Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Talanx AG:企業の戦略・SWOT・財務情報
    Talanx AG - Strategy, SWOT and Corporate Finance Report Summary Talanx AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Dynemic Products Ltd.:企業の戦略・SWOT・財務情報
    Dynemic Products Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dynemic Products Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Inter Pipeline Ltd (IPL):企業の財務・戦略的SWOT分析
    Inter Pipeline Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Impax Laboratories Inc (IPXL)-製薬・医療分野:企業M&A・提携分析
    Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous sy …
  • NEX Group plc.:企業の戦略的SWOT分析
    NEX Group plc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Aero-Tech Engineering, Inc.:企業の戦略・SWOT・財務情報
    Aero-Tech Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary Aero-Tech Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • viDA Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary viDA Therapeutics Inc (viDA) is a biopharmaceutical company that discovers, develops and commercializes novel and targeted therapeutics for the treatment of autoimmune and age-related chronic inflammatory diseases. The company’s lead product candidate include VTI-1002, is in a topical formul …
  • Honkarakenne Oyj (HONBS):企業の財務・戦略的SWOT分析
    Honkarakenne Oyj (HONBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Korea Gas Corp (036460):石油・ガス:M&Aディール及び事業提携情報
    Summary Korea Gas Corp (KOGAS) is a vertically integrated natural gas company active in upstream midstream and downstream segments of natural gas industry. It explores, produces and distributes natural gas. The company also purifies and sells by-products; imports and exports natural gas and liquefie …
  • WNDM Medical Inc (WNDM):医療機器:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • RP Management LLC-製薬・医療分野:企業M&A・提携分析
    Summary RP Management LLC (RP Management) is a life sciences financing company which offers biopharmaceutical products. Its products portfolio includes rituxan, atripla, thalomid, myozyme, lexiscan, januvia, onglyza, lyrica, prezista, letairis, rotateq, cubicin, savella, neupogen, and others. The co …
  • Gokul Refoils & Solvent Ltd. (GOKULEQ):企業の財務・戦略的SWOT分析
    Gokul Refoils & Solvent Ltd. (GOKULEQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • J D Wetherspoon plc:企業の戦略・SWOT・財務情報
    J D Wetherspoon plc - Strategy, SWOT and Corporate Finance Report Summary J D Wetherspoon plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Lekoil Ltd (LEK):企業の財務・戦略的SWOT分析
    Summary Lekoil Ltd (Lekoil) is an oil and gas exploration and production company with interests in Nigeria and Namibia. The company owns oil and gas exploration and production properties such as Otakikpo marginal field, Nigeria Dahomey Basin OPL310 and Nigeria Dahomey Basin OPL 325 in Nigeria, and B …
  • Medicago Inc-製薬・医療分野:企業M&A・提携分析
    Summary Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a biopharmaceutical company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. Its pipeline …
  • Save The Children Federation Inc:企業の戦略的SWOT分析
    Save The Children Federation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Ferring International Center SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ferring International Center SA (Ferring) researches, develops and markets pharmaceutical products. The company offers pharmaceutical products in the fields of reproductive health, gastroenterology, endocrinology, urology and orthopedics. Some of the marketed products include Rekovelle (foll …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆